Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $31,351 - $34,884
150 New
150 $32,000
Q3 2023

Nov 15, 2023

SELL
$201.05 - $221.7 $402 - $443
-2 Reduced 1.29%
153 $30,000
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $635 - $723
-3 Reduced 1.9%
155 $37,000
Q1 2023

May 22, 2023

BUY
$213.32 - $257.83 $26,025 - $31,455
122 Added 338.89%
158 $36,000
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $26,238 - $31,713
-123 Reduced 77.36%
36 $16,000
Q3 2022

Nov 15, 2022

SELL
$204.81 - $262.19 $614 - $786
-3 Reduced 1.85%
159 $33,000
Q1 2022

May 11, 2022

SELL
$259.82 - $298.18 $519 - $596
-2 Reduced 1.22%
162 $42,000
Q4 2021

Mar 09, 2022

SELL
$271.6 - $314.21 $1,086 - $1,256
-4 Reduced 2.38%
164 $52,000
Q2 2021

Aug 23, 2021

SELL
$251.87 - $278.14 $755 - $834
-3 Reduced 1.75%
168 $51,000
Q1 2021

Apr 28, 2021

SELL
$204.88 - $255.03 $1,024 - $1,275
-5 Reduced 2.84%
171 $44,000
Q3 2020

Nov 30, 2020

BUY
$167.03 - $201.3 $167 - $201
1 Added 0.57%
176 $35,000
Q2 2020

Aug 17, 2020

SELL
$113.31 - $182.44 $679 - $1,094
-6 Reduced 3.31%
175 $29,000
Q3 2019

Nov 08, 2019

SELL
$159.77 - $178.1 $319 - $356
-2 Reduced 1.09%
181 $30,000
Q1 2019

May 17, 2019

BUY
$123.7 - $156.3 $4,700 - $5,939
38 Added 26.21%
183 $28,000
Q4 2018

Feb 13, 2019

SELL
$120.82 - $174.09 $966 - $1,392
-8 Reduced 5.23%
145 $18,000
Q3 2018

Nov 13, 2018

SELL
$167.67 - $188.27 $1,173 - $1,317
-7 Reduced 4.38%
153 $24,000
Q2 2018

Jul 31, 2018

BUY
$160.33 - $189.41 $160 - $189
1 Added 0.63%
160 $30,000
Q1 2018

May 21, 2018

BUY
$161.53 - $178.11 $2,099 - $2,315
13 Added 8.9%
159 $26,000
Q4 2017

Feb 01, 2018

BUY
$147.99 - $163.95 $21,606 - $23,936
146
146 $23,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.